A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2011
10/27/2011	US20110263612 Compounds that modulate intracellular calcium
10/27/2011	US20110263606 Solid oral dosage forms comprising tadalafil
10/27/2011	US20110263594 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors
10/27/2011	US20110263593 NOVEL IMIDAZO[1,2-a]PYRIMIDINE DERIVATIVES, METHOD FOR THE PREPARATION THEREOF, USE THEREOF AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND NOVEL USE, IN PARTICULAR AS MET INHIBITORS
10/27/2011	US20110263589 Method for preventing or treating a glucocorticoid receptor-related disease
10/27/2011	US20110263577 Novel oxadiazolyl-diazabicyclononane derivatives and their medical use
10/27/2011	US20110263556 New Compounds
10/27/2011	US20110263550 Therapeutic agent for chronic obstructive pulmonary disease
10/27/2011	US20110263549 4-dimethylamino-phenyl-substituted naphthyridines, and use thereof as medicaments
10/27/2011	US20110263541 Kinase inhibitors and their use as pharmaceutical agents
10/27/2011	US20110263531 Methods for the treatment and amelioration of atopic dermatitis
10/27/2011	US20110263526 Nitric Oxide Releasing Prodrugs of Therapeutic Agents
10/27/2011	US20110263519 Regulators of the hedgehog pathway, compositions and uses related thereto
10/27/2011	US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011	US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011	US20110263483 Compositions and methods for treating pathologic angiogenesis and vascular permeability
10/27/2011	US20110263478 Sur1 inhibitors for therapy
10/27/2011	US20110262547 Process for preparing carrier particles for dry powders for inhalation
10/27/2011	US20110262543 Process for providing particles with reduced electrostatic charges
10/27/2011	US20110262535 Low Dose Topiramate / Phentermine Composition and Methods of Use Thereof
10/27/2011	US20110262502 Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
10/27/2011	US20110262498 Biologic Scaffold for Prevention of Pulmonary Fibrosis
10/27/2011	US20110262466 Compositions containing thrombomodulin domains and uses thereof
10/27/2011	US20110262454 Novel anti-cd38 antibodies for the treatment of cancer
10/27/2011	US20110262449 Method for the treatment of gout or pseudogout
10/27/2011	US20110262446 Use of igf-ii/igf-iie binding proteins for the treatment and prevention of systemic sclerosis associated pulmonary fibrosis
10/27/2011	US20110262445 Anti-il-12/il-23 antibodies
10/27/2011	US20110262441 Method for selective control of helper t cell function
10/27/2011	US20110262438 Biological materials related to cxcr7
10/27/2011	US20110262435 Il-13 binding agents
10/27/2011	US20110262429 Human timp-1 antibodies
10/27/2011	US20110262422 Orally administrable dosage forms comprising angiogenin and uses thereof
10/27/2011	US20110262420 Inhalant comprising modified superoxide dismutase
10/27/2011	US20110262419 Specifically targeted catalytic antagonists and uses thereof
10/27/2011	US20110262396 Combination treatments comprising protease binding proteins for inflammatory disorders
10/27/2011	US20110262386 Methods of treating inflammation
10/27/2011	US20110262384 Pharmaceutical Polypeptide Dry Powder Aerosol Formulation and Method of Preparation
10/27/2011	US20110262379 Maleamic Acid Polymer Derivatives and Their Bioconjugates
10/27/2011	US20110262369 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug
10/27/2011	US20110262368 C21 thioethers as glucocorticoid receptor agonists
10/27/2011	CA2796725A1 Uses of natriuretic peptide constructs
10/26/2011	EP2380891A1 Substituted piperidino-dihydrothienopyrimidines
10/26/2011	EP2380890A1 New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
10/26/2011	EP2380877A1 Pyridine-3-carboxyamide derivative
10/26/2011	EP2380569A2 Osmolyte for treating allergic or viral airway illnesses
10/26/2011	EP2379562A1 Bicyclic pyranone derivatives as nicotinic acid receptor agonists
10/26/2011	EP2379538A2 Heterocyclic compounds as phosphodiesterase inhibitors
10/26/2011	EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011	EP2379523A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
10/26/2011	EP2379518A1 Thiadiazole-substituted arylamides
10/26/2011	EP2379507A1 Sulfonamide compounds for the treatment of respiratory disorders
10/26/2011	EP2379174A1 Pharmaceutical product comprising a p38 kinase inhibitor and a second active ingredient
10/26/2011	EP2379173A1 Anti-snoring composition containing a thermogelling polymer
10/26/2011	EP2379102A1 Fibcd1 for the prevention and treatment of diseases
10/26/2011	EP2379081A1 Treatment of diarrhoea
10/26/2011	EP1916245B1 Indole derivative having pgd2 receptor antagonist activity
10/26/2011	EP1864994B1 Par-2 agonist
10/26/2011	EP1684719B1 Alpha 1-antitrypsin compositions and treatment methods using such compositions
10/26/2011	EP1518855B1 Diaminopyrimidinecarboxa mide derivative
10/26/2011	EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/26/2011	CN1939449B Infantile heat-clearing and antitussive dispersing tablets
10/26/2011	CN1823961B Compound Chinese medicine for treating cough and panting, acute bronchitis caused by common cold and its preparation method
10/26/2011	CN102227430A Modulators of cystic fibrosis transmembrane conductance regulator
10/26/2011	CN102227424A Modulators of cystic fibrosis transmembrane conductance regulator
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102226791A Method for determining dehydroandrographolide content in Ganmaoqing capsule by high performance liquid chromatography
10/26/2011	CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/26/2011	CN102225193A Traditional Chinese medicine composition for controlling recurrent respiratory tract infection in children
10/26/2011	CN102225168A Mongolian medicine for treating pharyngitis
10/26/2011	CN102225155A Medicament composition for treating pulmonary fibrosis
10/26/2011	CN102225154A Medicament composition for treating pulmonary fibrosis
10/26/2011	CN102225152A Preparation method of Maiwei rehmannia oral preparation
10/26/2011	CN102225144A Traditional Chinese medicine compound for treating cough and asthma and preparation method thereof
10/26/2011	CN102225141A Traditional Chinese medicine tablet for treating chronic faucitis
10/26/2011	CN102225133A Ephedra and blackberry lily oral liquid
10/26/2011	CN102225131A Traditional Chinese medicine for resisting viruses
10/26/2011	CN102225116A Medicine for treating rhinitis and preparation method thereof
10/26/2011	CN102225111A Traditional Chinese medicine granule for treating headache caused by rhinitis and preparation method thereof
10/26/2011	CN102225110A Propolis wine with heydyotis and its preparation method
10/26/2011	CN102225093A Preparation of Magnolia flower volatile oil soft capsule for treating allergic rhinitis and associated diseases
10/26/2011	CN102225074A Injection for treating spring allergy and allergic asthma and preparation method thereof
10/26/2011	CN102225073A Injection for treating spring allergy and allergic asthma and preparation method thereof
10/26/2011	CN102225065A Parcetamol pseudoephedrine hydrochloride and dextromethorphan hydrochloride capsule and preparation method thereof
10/26/2011	CN102225060A Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production
10/26/2011	CN102225057A Application of oxymatrine-containing composition in preparing inhalant antiasthmatic medicament
10/26/2011	CN102225056A Use of matrine-containing composition in preparing inhalation antiasthmatics
10/26/2011	CN102225049A Preparation method of ambroxol hydrochloride injection with stable pH value
10/26/2011	CN101972283B Preparation method of common wedgelet fern herb total flavone
10/26/2011	CN101884654B Process for preparing bupleurum chinense injection
10/26/2011	CN101869656B Chinese medicinal preparation for treating cough with asthma and preparation method thereof
10/26/2011	CN101780211B Traditional Chinese medicine for treating infantile chronic cough and asthma
10/26/2011	CN101757255B Traditional Chinese medicine for treating chronic rhinitis
10/26/2011	CN101671344B Eriosema chinense flavonoid extract and extracting method and application thereof
10/26/2011	CN101647885B Medicine composition for treating coughs
10/26/2011	CN101474381B Medicament for treating acute and chronic rhinitis as well as preparation method thereof and nasal cavity medicine delivery device
10/26/2011	CN101444331B Ultrahigh-pressure extraction method of honeysuckle flower, wild chrysanthemum and mulberry leaf and application of extract liquid thereof
10/26/2011	CN101348761B Health care wine
10/26/2011	CN101317973B Decoction medicament for treating acute sinusitis
10/26/2011	CN101313986B Orally taken traditional Chinese medicine for treating cough caused by dryness-heat

1 ... 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 ... 878